General information

Announcements(2)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 16, 2026

Tue. Mar 17, 2026

Wed. Mar 18, 2026

web_header.png

web_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Therapeutic Targeting of Epigenomic Dysregulation in Inflammation-Associated Myelodysplastic Syndrome (MDS)

When inflammation and immune responses deviate from their inherent defensive functions, they undergo plastic changes that underlie diverse pathological states such as cancer, neurodegeneration, and infectious diseases. This dynamic responsiveness contributes to homeostasis at times, while promoting disease at others. We focus on the interplay between the breakdown of immune response and inflammatory stress control at the molecular level (micro) and resistance to drug therapy alongside systemic disease-modifying factors (macro). Through cutting-edge research in the nervous system, muscle tissue, and hematopoietic system, we will multifacetedly examine how the plasticity of inflammation and immunity influences biological functions and disease susceptibility, envisioning novel intervention strategies.

The 99th Annual Meeting of the Japanese Pharmacological Society

Presentation Information

[1-S-23]Therapeutic Targeting of Epigenomic Dysregulation in Inflammation-Associated Myelodysplastic Syndrome (MDS)

Keywords:

Password required to view

Comment